We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine.
- Authors
Albayrak, Yakup; Beyazyüz, Murat; Abbak, Özlem; Altındağ, Ece
- Abstract
Rabbit Syndrome is an uncommon side effect of antipsychotic treatment. Although it is usually associated with typical antipsychotics, it can also be related to atypical antipsychotics. Anticholinergics are the most accepted treatment approach in treating Rabbit Syndrome. Fluvoxamine is a member of selective serotonin reuptake inhibitors and it is a potent agonist of sigma 1 receptors. In this article, we report a Rabbit Syndrome case who has benefited from fluvoxamine, in terms of both depressive disorder and Rabbit Syndrome; and present the data on the effects of sigma 1 agonist fluvoxamine on numerous movement disorders.
- Subjects
FLUVOXAMINE; ANTIPSYCHOTIC agents; MOVEMENT disorders
- Publication
Clinical Psychopharmacology & Neuroscience, 2019, Vol 17, Issue 1, p134
- ISSN
1738-1088
- Publication type
Case Study
- DOI
10.9758/cpn.2019.17.1.134